文献速递瓣膜外科

HFA-PEFF评分对孤立性主动脉瓣置换术患者的长期预后价值

Long-term prognostic value of Heart Failure Association Pretest Assessment, Echocardiography and Natriuretic Peptide, Functional Testing, Final Etiology score in patients undergoing isolated surgical aortic valve replacement for severe aortic stenosis.
PubMed 文献 · J Thorac Cardiovasc Surg · 2025-06-25

本研究回顾性分析193例因重度主动脉瓣狭窄伴左室射血分数保留(≥50%)行孤立性外科主动脉瓣置换术的患者,评估HFA-PEFF评分对长期心血管死亡和不良心脏事件的预测价值。

要点

  • HFA-PEFF评分可预测孤立性SAVR术后长期心血管死亡和不良事件。
  • 术前高评分患者术后6个月56%改善至中等评分,风险显著降低。

核心结论

  • HFA-PEFF评分可预测重度主动脉瓣狭窄伴射血分数保留行孤立性SAVR患者的长期心血管死亡和不良心脏事件。

研究设计与样本

  • 回顾性分析2012年10月至2017年4月间193例因重度主动脉瓣狭窄伴左室射血分数≥50%行孤立性外科主动脉瓣置换术的患者。

主要发现

  • 中位随访5.9年,心血管死亡13例(6.7%),因心衰或心律失常再入院22例(11.4%)。
  • 术前高评分患者中56%在6个月时改善至中等评分,其风险显著低于持续高评分者,无改善至低评分者。

关键数值与推荐

  • HFA-PEFF评分≥5分为高评分,2-4分为中等评分,≤1分为低评分。

临床怎么用

  • 对于重度主动脉瓣狭窄伴射血分数保留拟行孤立性SAVR的患者,可用HFA-PEFF评分进行术前风险分层。
  • 术后评分改善至中等评分者预后优于持续高评分者,提示动态评估评分变化有临床意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Heart Failure Association Pretest assessment, Echocardiography and Natriuretic Peptide, Functional Testing, Final Etiology score was proposed as a diagnostic tool for heart failure with preserved left ventricular ejection fraction. This study aimed to evaluate the prognostic value of the Heart Failure Association Pretest assessment, Echocardiography and Natriuretic Peptide, Functional Testing, Final Etiology score in patients undergoing isolated surgical aortic valve replacement for severe aortic stenosis with preserved ventricular ejection fraction. METHODS: A total of 193 patients who underwent isolated surgical aortic valve replacement for severe aortic stenosis with preserved ventricular ejection fraction (≥50%) between October 2012 and April 2017 were retrospectively analyzed. Patients with a Heart Failure Association Pretest assessment, Echocardiography and Natriuretic Peptide, Functional Testing, Final Etiology score 5 points or more were categorized as having a "high score," 2 to 4 points as an "intermediate score," and 1 point or less as a "low score." The primary end point was a composite of cardiovascular mortality and adverse cardiac events. RESULTS: During a median follow-up of 5.9 years, cardiovascular death occurred in 13 patients (6.7%) and 22 patients (11.4%) were readmitted for heart failure or arrhythmia. Eighty-two patients (54.4%) exhibited a high score, which was associated with a higher risk of the primary end point, compared with those with an intermediate and a low score (log-rank, P = .0030). In multivariable analysis, the Heart Failure Association Pretest assessment, Echocardiography and Natriuretic Peptide, Functional Testing, Final Etiology score was identified as an independent predictor of the primary end point (hazard ratio, 1.47; 95% CI, 1.07-2.10; P = .023). Among patients with a preoperative high score, 56% improved to an intermediate score at 6 months, with a significantly lower risk of the primary end point than those with a persistent high score; none improved to a low score. CONCLUSIONS: The Heart Failure Association Pretest assessment, Echocardiography and Natriuretic Peptide, Functional Testing, Final Etiology score predicts the long-term cardiovascular mortality and adverse cardiac events in patients undergoing isolated surgical aortic valve replacement for severe aortic stenosis with persevered ventricular ejection fraction.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ohmori T, Hiraoka A, Hamada Y, et al. Long-term prognostic value of Heart Failure Association Pretest Assessment, Echocardiography and Natriuretic Peptide, Functional Testing, Final Etiology score in patients undergoing isolated surgical aortic valve replacement for severe aortic stenosis. J Thorac Cardiovasc Surg. 2025. PMID: 40578547. doi:10.1016/j.jtcvs.2025.06.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。